Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco/nicotine Products by Nontargeted GC–MS/MS Analysis
Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes...
Saved in:
Published in | Chemical research in toxicology Vol. 37; no. 11; pp. 1884 - 1902 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
18.11.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC–MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence. |
---|---|
AbstractList | Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence. Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence.Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb) and albumin. New nicotine and tobacco products are discussed as less harmful forms of tobacco use compared to smoking combustible cigarettes (CC) due to reduced exposure to harmful constituents. Hence, the adduct profile in users of various tobacco/nicotine products is expected to differ characteristically. In this article, we present a novel nontargeted screening strategy using GC-MS/MS for Hb adducts based on the analysis of the respective derivatized N-terminal valine adducts after modified Edman degradation. We analyzed blood samples from a clinical study with habitual users of CCs, electronic cigarettes, heated tobacco products (HTPs), oral tobacco, nicotine replacement therapy products and nonusers of any tobacco/nicotine products. Our nontargeted approach revealed significant differences in the Hb adduct profiles of the investigated tobacco/nicotine product user groups. Adduct identification was performed by means of an internal database, retention time estimations based on the theoretical boiling points, as well as in-house synthesized reference compounds. Several chemicals that form adducts with Hb could be identified: methylating and ethylating agents, ethylene oxide, acrylonitrile, acrylamide, glycidamide and 4-hydroxybenzaldehyde. Levels were elevated in smokers compared to all other groups for Hb adducts from methylating agents, ethylene oxide, acrylonitrile, acrylamide and glycidamide. Our approach revealed higher concentrations of Hb adducts formed by ethylation, acrylamide and glycidamide in users of HTPs compared to nonusers. However, concentrations for the latter two were still lower than in smokers. Due to their long half-lives, Hb adducts related to acrylonitrile, acrylamide (glycidamide), and ethylene oxide exposure may be useful for the biochemical verification of subjects̀ compliance in longitudinal and cross-sectional studies with respect to smoking and HTP use/abstinence. |
Author | Scherer, Max Burkhardt, Therese Pilz, Fabian Scherer, Gerhard Pluym, Nikola |
AuthorAffiliation | ABF, Analytisch-Biologisches Forschungslabor GmbH |
AuthorAffiliation_xml | – name: ABF, Analytisch-Biologisches Forschungslabor GmbH |
Author_xml | – sequence: 1 givenname: Fabian surname: Pilz fullname: Pilz, Fabian – sequence: 2 givenname: Therese surname: Burkhardt fullname: Burkhardt, Therese – sequence: 3 givenname: Gerhard orcidid: 0000-0001-7456-3402 surname: Scherer fullname: Scherer, Gerhard – sequence: 4 givenname: Max surname: Scherer fullname: Scherer, Max – sequence: 5 givenname: Nikola orcidid: 0000-0003-4954-591X surname: Pluym fullname: Pluym, Nikola email: nikola.pluym@abf-lab.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39405427$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkbFu2zAQhokiReMkfYWAYxfZPJKypNFw2yRAkgZwAnQTKOqUMpBIl6SAesuYvW_YJwkFu-2Y6YC777vh_0_IkXUWCTkHNgfGYaF0mOsfOHgM0f2aS80Yz8t3ZAY5Z1nOgB2RGSsrkXFefj8mJyE8MQbJLT6QY1FJlktezMjLVYs2ms5oFY2z1HV0s0U9LeglDu6xd42xdNW2o470TsWI3gaaVg8BfZj4z6br0Kcv9N41Smu3sEa7aCzSO-8mL9BmR2-djco_YsSWXqz_PP--2SxuNnRlVb8LJpyR953qA348zFPy8PXL_foyu_52cbVeXWdKMIhZIzTKCrqKS8WAc1bKtlEgsMyhlbJZ6gJ0p5dSLEFUPK-gZaKQUgOCKlQnTsmn_d-tdz_HlF49mKCx75VFN4ZaABSs4BWHhJ4f0LEZsK233gzK7-q_6SVguQe0dyF47P4hwOqppjrVVP-vqT7UlES-F6f7kxt9CiG8Jb0Cy6-ctQ |
Cites_doi | 10.1021/acs.chemrestox.8b00173 10.1006/abio.1996.0322 10.1016/B978-0-12-818158-4.00008-X 10.1093/toxsci/kfi307 10.1017/S002966510800712X 10.1155/2009/153472 10.1021/acs.chemrestox.2c00020 10.1021/tx000247+ 10.1021/tx7002068 10.1158/1055-9965.EPI-05-0456 10.1016/S0021-9258(19)62688-8 10.1016/j.mrgentox.2004.10.013 10.1021/acs.chemrestox.7b00234 10.1016/j.fct.2016.03.028 10.3390/separations8100171 10.21105/joss.01686 10.1016/j.jchromb.2006.06.003 10.1016/0003-2697(86)90524-5 10.2478/cttr-2013-0668 10.1016/j.mrfmmm.2005.05.004 10.1078/1438-4639-00324 10.3389/fonc.2022.925743 10.1016/j.jchromb.2018.03.048 10.1111/bcpt.13393 10.1016/j.addbeh.2013.11.002 10.1093/carcin/12.2.257 10.1016/j.envint.2020.105545 10.1038/s41598-017-05930-9 10.1007/s00216-022-04143-y 10.1111/bcpt.12715 10.1021/tx5002749 10.1016/j.toxlet.2017.07.896 10.1016/j.mrgentox.2004.10.012 10.1016/j.jchromb.2010.03.034 10.1007/s00204-021-03165-2 10.1016/j.jchromb.2009.11.043 10.1038/nrc1190 10.1007/s10654-020-00625-4 10.1016/j.envres.2021.112659 10.1021/acs.estlett.1c00648 10.1021/cr300391r 10.1016/j.chroma.2007.07.044 10.1016/j.fochx.2022.100538 10.1021/tx9501041 10.1021/acs.chemrestox.7b00114 10.1124/dmd.105.006387 10.1021/acs.chemrestox.5b00287 10.1016/0165-1218(88)90046-8 10.1039/C8NP00074C 10.1016/S1470-2045(08)70173-6 10.1046/j.1440-1843.2003.00507.x 10.1016/j.crtox.2022.100067 10.1016/j.sjbs.2023.103704 10.9734/BJMMR/2015/16285 10.1093/carcin/9.6.875 10.1016/j.fct.2012.07.058 10.3390/ht8010006 10.1016/0076-6879(94)31045-9 10.1073/pnas.68.1.160 10.1007/978-3-319-67903-7_1 10.1186/1477-7517-8-11 10.1021/acs.chemrestox.2c00262 10.1093/carcin/23.12.2081 10.1016/j.toxrep.2019.05.009 10.1289/ehp.99-1567046 10.1080/10937404.2020.1852988 10.1016/j.conctc.2021.100794 10.1016/S1570-0232(02)00172-1 10.1002/rcm.8509 10.1021/tx4004352 10.1136/tc.2007.024158 10.2478/cttr-2021-0014 10.1007/s004200050353 10.1093/ije/dyr236 10.1021/acs.chemrestox.1c00111 10.1016/S0278-6915(00)00093-4 10.1007/s002040100235 10.1080/02772248609357133 10.3390/metabo12020154 10.1186/1471-2105-11-395 10.1093/toxsci/kfm091 10.3891/acta.chem.scand.40b-0453 10.1016/j.talanta.2020.121339 10.1016/j.fct.2012.04.004 10.1016/j.talanta.2017.09.092 10.1093/carcin/10.11.2123 10.1007/s11356-021-15444-7 10.1373/clinchem.2005.061408 10.1021/jf020302f 10.1016/0009-2797(92)90016-E 10.3390/toxics7010007 10.1007/s11356-022-23782-3 10.1002/jms.3083 10.1002/dta.3372 10.1016/0009-2797(95)03632-V 10.1021/tx700235t 10.1021/acs.jafc.5b02622 10.1093/carcin/7.9.1519 10.1016/j.fct.2021.112799 10.1183/16000617.0034-2016 10.1371/journal.pone.0154387 10.1038/s41370-023-00574-6 10.1007/s00204-018-2373-y 10.1002/em.21824 10.1093/carcin/23.11.1903 10.1021/acs.chemrestox.0c00092 10.1016/S0140-6736(20)30752-2 10.1007/s00204-022-03349-4 10.1289/ehp.1308015 10.1021/acs.chemrestox.6b00463 10.1021/tx960113p 10.1021/acs.chemrestox.6b00366 |
ContentType | Journal Article |
Copyright | 2024 The Authors. Published by American Chemical Society |
Copyright_xml | – notice: 2024 The Authors. Published by American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/acs.chemrestox.4c00258 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1520-5010 |
EndPage | 1902 |
ExternalDocumentID | 39405427 10_1021_acs_chemrestox_4c00258 a294777810 |
Genre | Journal Article |
GroupedDBID | --- -~X 29B 4.4 55A 5GY 5RE 5VS 7~N AABXI ABJNI ABMVS ABQRX ABUCX ACGFS ACJ ACS ADHLV AEESW AENEX AFEFF AGXLV AHGAQ ALMA_UNASSIGNED_HOLDINGS AQSVZ BAANH CS3 CUPRZ EBS ED~ F5P GGK GNL IH9 IHE JG~ LG6 P2P ROL TN5 UI2 UPT VF5 VG9 W1F YZZ AAYXX ABBLG ABLBI CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-a301t-b3ce491f924a0122084dba13e851d44b6c71cfc64361392591d03744c1e1a7af3 |
IEDL.DBID | ACS |
ISSN | 0893-228X 1520-5010 |
IngestDate | Fri Jul 11 06:04:05 EDT 2025 Mon Jul 21 05:59:31 EDT 2025 Tue Jul 01 03:37:37 EDT 2025 Tue Nov 19 03:21:03 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Language | English |
License | https://doi.org/10.15223/policy-029 https://doi.org/10.15223/policy-037 https://doi.org/10.15223/policy-045 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a301t-b3ce491f924a0122084dba13e851d44b6c71cfc64361392591d03744c1e1a7af3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-7456-3402 0000-0003-4954-591X |
PMID | 39405427 |
PQID | 3117072921 |
PQPubID | 23479 |
PageCount | 19 |
ParticipantIDs | proquest_miscellaneous_3117072921 pubmed_primary_39405427 crossref_primary_10_1021_acs_chemrestox_4c00258 acs_journals_10_1021_acs_chemrestox_4c00258 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-11-18 |
PublicationDateYYYYMMDD | 2024-11-18 |
PublicationDate_xml | – month: 11 year: 2024 text: 2024-11-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Chemical research in toxicology |
PublicationTitleAlternate | Chem. Res. Toxicol |
PublicationYear | 2024 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | ref45/cit45 ref99/cit99 ref3/cit3 ref81/cit81 ref16/cit16 ref52/cit52 ref114/cit114 ref23/cit23 ref115/cit115 ref116/cit116 ref110/cit110 ref111/cit111 ref2/cit2 ref112/cit112 ref77/cit77 ref113/cit113 ref71/cit71 ref117/cit117 ref20/cit20 ref48/cit48 ref118/cit118 ref74/cit74 ref35/cit35 ref89/cit89 ref19/cit19 ref93/cit93 ref96/cit96 International Agency for Research on Cancer (ref86/cit86) 2022 ref107/cit107 ref120/cit120 ref109/cit109 ref13/cit13 ref122/cit122 ref105/cit105 ref61/cit61 ref67/cit67 ref38/cit38 ref128/cit128 ref90/cit90 ref124/cit124 ref64/cit64 ref126/cit126 ref54/cit54 ref6/cit6 ref18/cit18 ref65/cit65 ref97/cit97 ref101/cit101 ref11/cit11 ref102/cit102 ref29/cit29 Stanfill S. B. (ref119/cit119) 2020 ref76/cit76 ref32/cit32 ref39/cit39 Van Sittert N. (ref42/cit42) 2002 ref43/cit43 ref80/cit80 ref133/cit133 ref28/cit28 ref132/cit132 ref91/cit91 ref55/cit55 ref12/cit12 ref66/cit66 ref22/cit22 ref121/cit121 ref33/cit33 ref87/cit87 ref106/cit106 ref129/cit129 ref44/cit44 World Health Organization (ref4/cit4) 2015; 989 ref70/cit70 ref125/cit125 ref9/cit9 ref27/cit27 ref63/cit63 Baker R. R. (ref98/cit98) 1999 ref56/cit56 ref8/cit8 ref31/cit31 ref59/cit59 ref85/cit85 ref34/cit34 ref37/cit37 Komsta L. (ref49/cit49) 2011 ref60/cit60 ref88/cit88 ref17/cit17 ref82/cit82 ref53/cit53 ref21/cit21 International Agency for Research on Cancer (ref7/cit7) 1985; 37 ref46/cit46 Gallage N. J. (ref108/cit108) 2018 R Core Team (ref50/cit50) 2023 ref24/cit24 ref78/cit78 ref36/cit36 ref83/cit83 ref79/cit79 ref100/cit100 ref25/cit25 ref103/cit103 ref72/cit72 ref14/cit14 ref57/cit57 Lewalter J. (ref123/cit123) 2002 World Health Organization (ref10/cit10) 2021 US Food and Drug Administration (ref5/cit5) 2012; 77 ref40/cit40 ref68/cit68 Rodgman A. (ref75/cit75) 2013 ref94/cit94 ref130/cit130 ref131/cit131 RStudio Team (ref51/cit51) 2023 ref26/cit26 ref73/cit73 ref69/cit69 ref15/cit15 ref62/cit62 ref41/cit41 ref58/cit58 ref95/cit95 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (ref92/cit92) 1999; 71 ref104/cit104 ref30/cit30 ref47/cit47 ref84/cit84 ref127/cit127 ref1/cit1 |
References_xml | – ident: ref36/cit36 doi: 10.1021/acs.chemrestox.8b00173 – ident: ref61/cit61 doi: 10.1006/abio.1996.0322 – start-page: 167 volume-title: Smokeless Tobacco Products year: 2020 ident: ref119/cit119 doi: 10.1016/B978-0-12-818158-4.00008-X – volume: 989 volume-title: WHO Study Group on Tobacco Product Regulation: Report on the Scientific Basis of Tobacco Product Regulation: Fifth Report of a WHO Study Group year: 2015 ident: ref4/cit4 – volume-title: World Agriculture Series year: 1999 ident: ref98/cit98 – ident: ref102/cit102 doi: 10.1093/toxsci/kfi307 – ident: ref17/cit17 doi: 10.1017/S002966510800712X – ident: ref37/cit37 doi: 10.1155/2009/153472 – ident: ref44/cit44 doi: 10.1021/acs.chemrestox.2c00020 – ident: ref32/cit32 doi: 10.1021/tx000247+ – volume-title: Package “Outliers” year: 2011 ident: ref49/cit49 – ident: ref80/cit80 doi: 10.1021/tx7002068 – ident: ref20/cit20 doi: 10.1158/1055-9965.EPI-05-0456 – ident: ref81/cit81 doi: 10.1016/S0021-9258(19)62688-8 – ident: ref38/cit38 doi: 10.1155/2009/153472 – ident: ref104/cit104 doi: 10.1016/j.mrgentox.2004.10.013 – start-page: 1 volume-title: The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace year: 2002 ident: ref42/cit42 – ident: ref77/cit77 doi: 10.1021/acs.chemrestox.7b00234 – ident: ref33/cit33 doi: 10.1016/j.fct.2016.03.028 – ident: ref47/cit47 doi: 10.3390/separations8100171 – ident: ref52/cit52 doi: 10.21105/joss.01686 – ident: ref59/cit59 doi: 10.1016/j.jchromb.2006.06.003 – ident: ref30/cit30 doi: 10.1016/0003-2697(86)90524-5 – ident: ref2/cit2 doi: 10.2478/cttr-2013-0668 – ident: ref101/cit101 doi: 10.1016/j.mrfmmm.2005.05.004 – ident: ref100/cit100 doi: 10.1078/1438-4639-00324 – ident: ref112/cit112 doi: 10.3389/fonc.2022.925743 – ident: ref63/cit63 doi: 10.1016/j.jchromb.2018.03.048 – ident: ref99/cit99 doi: 10.1111/bcpt.13393 – ident: ref9/cit9 doi: 10.1016/j.addbeh.2013.11.002 – ident: ref72/cit72 doi: 10.1093/carcin/12.2.257 – ident: ref133/cit133 doi: 10.1016/j.envint.2020.105545 – ident: ref91/cit91 doi: 10.1038/s41598-017-05930-9 – ident: ref122/cit122 doi: 10.1007/s00216-022-04143-y – ident: ref93/cit93 doi: 10.1111/bcpt.12715 – ident: ref34/cit34 doi: 10.1021/tx5002749 – ident: ref53/cit53 – ident: ref89/cit89 doi: 10.1016/j.toxlet.2017.07.896 – ident: ref103/cit103 doi: 10.1016/j.mrgentox.2004.10.012 – ident: ref31/cit31 doi: 10.1016/j.jchromb.2010.03.034 – volume-title: R: A Language and Environment for Statistical Computing year: 2023 ident: ref50/cit50 – ident: ref54/cit54 – ident: ref124/cit124 doi: 10.1007/s00204-021-03165-2 – ident: ref60/cit60 doi: 10.1016/j.jchromb.2009.11.043 – ident: ref19/cit19 doi: 10.1038/nrc1190 – ident: ref23/cit23 doi: 10.1007/s10654-020-00625-4 – ident: ref97/cit97 doi: 10.1016/j.envres.2021.112659 – ident: ref14/cit14 doi: 10.1021/acs.estlett.1c00648 – ident: ref24/cit24 doi: 10.1021/cr300391r – ident: ref105/cit105 doi: 10.1016/j.chroma.2007.07.044 – ident: ref68/cit68 doi: 10.1016/j.fochx.2022.100538 – ident: ref79/cit79 doi: 10.1021/tx9501041 – ident: ref74/cit74 doi: 10.1021/acs.chemrestox.7b00114 – ident: ref109/cit109 doi: 10.1124/dmd.105.006387 – ident: ref125/cit125 doi: 10.1021/acs.chemrestox.5b00287 – ident: ref69/cit69 doi: 10.1016/0165-1218(88)90046-8 – volume: 37 start-page: 1 year: 1985 ident: ref7/cit7 publication-title: IARC Monogr. Eval. Carcinog. Risks Hum. – ident: ref110/cit110 doi: 10.1039/C8NP00074C – ident: ref111/cit111 doi: 10.1016/S1470-2045(08)70173-6 – ident: ref113/cit113 doi: 10.1046/j.1440-1843.2003.00507.x – volume-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Human year: 2022 ident: ref86/cit86 – ident: ref46/cit46 doi: 10.1016/j.crtox.2022.100067 – ident: ref116/cit116 doi: 10.1016/j.sjbs.2023.103704 – ident: ref8/cit8 doi: 10.9734/BJMMR/2015/16285 – ident: ref71/cit71 doi: 10.1093/carcin/9.6.875 – ident: ref127/cit127 doi: 10.1016/j.fct.2012.07.058 – volume: 77 start-page: 20034 year: 2012 ident: ref5/cit5 publication-title: Fed. Regist. – ident: ref28/cit28 doi: 10.3390/ht8010006 – ident: ref64/cit64 doi: 10.1016/0076-6879(94)31045-9 – ident: ref11/cit11 doi: 10.1073/pnas.68.1.160 – ident: ref55/cit55 – start-page: 3 volume-title: Biotechnology of Natural Products year: 2018 ident: ref108/cit108 doi: 10.1007/978-3-319-67903-7_1 – ident: ref118/cit118 doi: 10.1186/1477-7517-8-11 – ident: ref84/cit84 doi: 10.1021/acs.chemrestox.2c00262 – ident: ref78/cit78 doi: 10.1093/carcin/23.12.2081 – ident: ref117/cit117 doi: 10.1016/j.toxrep.2019.05.009 – ident: ref120/cit120 – ident: ref58/cit58 doi: 10.1289/ehp.99-1567046 – ident: ref90/cit90 doi: 10.1080/10937404.2020.1852988 – ident: ref41/cit41 doi: 10.1016/j.conctc.2021.100794 – ident: ref27/cit27 doi: 10.1016/S1570-0232(02)00172-1 – ident: ref131/cit131 doi: 10.1002/rcm.8509 – ident: ref25/cit25 doi: 10.1021/tx4004352 – volume-title: The Chemical Components of Tobacco and Tobacco Smoke year: 2013 ident: ref75/cit75 – ident: ref3/cit3 doi: 10.1136/tc.2007.024158 – ident: ref1/cit1 doi: 10.2478/cttr-2021-0014 – ident: ref121/cit121 doi: 10.1007/s004200050353 – ident: ref21/cit21 doi: 10.1093/ije/dyr236 – ident: ref107/cit107 doi: 10.1021/acs.chemrestox.1c00111 – ident: ref65/cit65 doi: 10.1016/S0278-6915(00)00093-4 – ident: ref73/cit73 doi: 10.1007/s002040100235 – ident: ref29/cit29 doi: 10.1080/02772248609357133 – ident: ref16/cit16 doi: 10.3390/metabo12020154 – volume-title: WHO Report on the Global Tobacco Epidemic, 2021: Addressing New and Emerging Products year: 2021 ident: ref10/cit10 – ident: ref48/cit48 doi: 10.1186/1471-2105-11-395 – ident: ref106/cit106 doi: 10.1093/toxsci/kfm091 – ident: ref130/cit130 doi: 10.3891/acta.chem.scand.40b-0453 – ident: ref39/cit39 doi: 10.1016/j.talanta.2020.121339 – ident: ref96/cit96 doi: 10.1016/j.fct.2012.04.004 – ident: ref62/cit62 doi: 10.1016/j.talanta.2017.09.092 – ident: ref66/cit66 doi: 10.1093/carcin/10.11.2123 – ident: ref87/cit87 doi: 10.1007/s11356-021-15444-7 – ident: ref12/cit12 doi: 10.1373/clinchem.2005.061408 – ident: ref67/cit67 – ident: ref95/cit95 doi: 10.1021/jf020302f – ident: ref56/cit56 – ident: ref70/cit70 doi: 10.1016/0009-2797(92)90016-E – ident: ref128/cit128 doi: 10.3390/toxics7010007 – ident: ref57/cit57 – ident: ref88/cit88 doi: 10.1007/s11356-022-23782-3 – ident: ref114/cit114 doi: 10.1002/jms.3083 – volume-title: RStudio: Integrated Development Environment for R year: 2023 ident: ref51/cit51 – ident: ref45/cit45 doi: 10.1002/dta.3372 – ident: ref82/cit82 doi: 10.1016/0009-2797(95)03632-V – ident: ref13/cit13 doi: 10.1021/tx700235t – ident: ref115/cit115 doi: 10.1021/acs.jafc.5b02622 – ident: ref85/cit85 doi: 10.1093/carcin/7.9.1519 – ident: ref94/cit94 doi: 10.1016/j.fct.2021.112799 – ident: ref22/cit22 doi: 10.1183/16000617.0034-2016 – ident: ref15/cit15 doi: 10.1371/journal.pone.0154387 – ident: ref40/cit40 doi: 10.1038/s41370-023-00574-6 – start-page: 35 volume-title: The MAK-Collection for Occupational Health and Safety: Annual Thresholds and Classifications for the Workplace year: 2002 ident: ref123/cit123 – ident: ref126/cit126 doi: 10.1007/s00204-018-2373-y – ident: ref83/cit83 doi: 10.1002/em.21824 – ident: ref76/cit76 doi: 10.1093/carcin/23.11.1903 – volume: 71 volume-title: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans year: 1999 ident: ref92/cit92 – ident: ref132/cit132 doi: 10.1021/acs.chemrestox.0c00092 – ident: ref6/cit6 doi: 10.1016/S0140-6736(20)30752-2 – ident: ref43/cit43 doi: 10.1007/s00204-022-03349-4 – ident: ref18/cit18 doi: 10.1289/ehp.1308015 – ident: ref35/cit35 doi: 10.1021/acs.chemrestox.6b00463 – ident: ref129/cit129 doi: 10.1021/tx960113p – ident: ref26/cit26 doi: 10.1021/acs.chemrestox.6b00366 |
SSID | ssj0011027 |
Score | 2.4474525 |
Snippet | Tobacco smoke contains several electrophilic constituents which are capable of forming adducts with nucleophilic sites in DNA and proteins like hemoglobin (Hb)... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1884 |
SubjectTerms | Adult Electronic Nicotine Delivery Systems Female Gas Chromatography-Mass Spectrometry Hemoglobins - analysis Hemoglobins - chemistry Hemoglobins - metabolism Humans Male Middle Aged Nicotine - analysis Nicotine - blood Nicotine - chemistry Nicotine - metabolism Tandem Mass Spectrometry Tobacco Products - analysis |
Title | Identification of Specific Hemoglobin Adduct Patterns in Users of Different Tobacco/nicotine Products by Nontargeted GC–MS/MS Analysis |
URI | http://dx.doi.org/10.1021/acs.chemrestox.4c00258 https://www.ncbi.nlm.nih.gov/pubmed/39405427 https://www.proquest.com/docview/3117072921 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lj9MwEB4tywUJ8Vhe5SUjob2waWvHeR2rwrJC6qqordRb5PihRWgTRFKJcuLInX_IL2EmTrZCqAKulm0l9tjz2ePvG4CXsXZZhH4isGERBVIVOsjSyAVSWGMyqUIbEt95dh6freS7dbQ-gPGeCL7gI6Vx8C_sJaWqqL4MpSY3nV6D6yJOEzpuTaaLq7gBtvDanlkYCJGue07w3n7IKen6d6e0B2m2Huf0NrzveTv-ocnH4aYphvrrnzKO__wzd-BWBz_ZxNvLXTiw5REcz71-9faELXd0rPqEHbP5Ttl6ewQ3_SUf89yle_Dd03xdd-_HKsfafPaurXNZkdrIh5JNDInKsnkr5VnWDItWRPKk-q-7BC0NW-LOonU1KtE2G8S-bO7FaGtWbNl5Vfo369awt9Of337MFqPZgvWSKvdhdfpmOT0LutQOgcIdpQmKUFuZcYenP0XBvXEqTaF4aBEAGimLWCdcO41wCeFGhkc0bkgoR2puuUqUCx_AYVmV9hEwRTWizAjnnEzHWmmTODVWmoR2slgO4BWOet4tzTpvo-6C51S4m4q8m4oBjHpLyD95vY-_tnjRG0yOS5PiLaq01abOQ8rqg4cXwQfw0FvSVZ-UkD6SInn8X1_3BG4IBFXEheTpUzhsPm_sMwRFTfG8XQe_AN6EDKU |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwEB3BcgBptcACS_k0EtoLm7Z2nDY5VoWlwLaq1FbqLXL8IaHVJiuSSltOHLnzD_klzMRpK5BWCK6WY9nx2PPs8XsD8LqnXRKhnwhsmEWBVJkOkjhygRTWmESq0IbEdx5PeqOF_LiMls3VBXFhsBMltlTWQfydugDvUBkO44IyVhRXbanJW8c34RYiEkGnrsFwtg0f4Bde4jMJAyHi5YYafG075Jt0-btvugZw1o7n9C4st12u35uct1dV1tZf_1Bz_I8x3YODBoyygbee-3DD5odwPPVq1usTNt-Rs8oTdsymO53r9SHs-ys_5plMD-C7J_265haQFY7V2e1dXeeiIO2RzzkbGJKYZdNa2DMvGRYtiPJJ9d826VoqNsd9Ruuik6OlVoiE2dRL05YsW7NJkfsX7Naw98Of336MZ53xjG0EVh7C4vTdfDgKmkQPgcL9pQqyUFuZcIdnQUWhvm4sTaZ4aBEOGimznu5z7TSCJwQfCR7YuCHZHKm55aqvXPgI9vIit4-BKaoRJUY452Tc1UqbvlNdpUl2J-nJFrzBv542C7VM6xi84CkV7qYibaaiBZ2NQaSXXv3jr1-82thNiguVoi8qt8WqTEPK8YNHGcFbcOQNatsmpaePpOg_-afevYTbo_n4LD37MPn0FO4IhFvEkuTxM9irvqzsc4RLVfaiXhq_AO66FQY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Li9swEB62WyiF0sf2lT5VKHvpOolsObHpKWSbbh8JhiSQQ8HIesCyrL3UDjQ99dh7_2F_SWcsO6GFpbRXIQvJmtF8o9F8A_ByoGwcop3wTJCFnpCZ8uIotJ7wjdaxkIEJKN95OhucLMX7Vbjag9dtLgxOosSRyjqIT1p9oW3DMMB71I5LOaeqFcWXrlBksaMrcJVid-R5jcbzbQgBv3A0n3Hg-X60atODLx2H7JMqf7dPl4DO2vhMbsGn7bTrNydn3XWVddXXPxgd_3Ndt-FmA0rZyEnRHdgz-QEcJo7VenPEFrskrfKIHbJkx3e9OYAb7uqPuYymu_DdJf_a5jaQFZbVVe5t3ee8IA6S05yNNFHNsqQm-MxLhk1LSv2k_sdN2ZaKLfC8Uaro5SixFSJiljiK2pJlGzYrcveS3Wj2dvzz24_pvDeds5Zo5R4sJ28W4xOvKfjgSTxnKi8LlBExt-gTSgr59SOhM8kDg7BQC5EN1JArqxBEIQiJ0XHjmuhzhOKGy6G0wX3Yz4vcPAQmqUcYa99aK6K-kkoPrexLRfQ78UB04BX-9bRR2DKtY_E-T6lxtxVpsxUd6LVCkV44FpC_fvGilZ0UFZaiMDI3xbpMA6r1gy6NzzvwwAnVdkwqUx8Kf_jon2b3HK4lx5P047vZh8dw3UfURcmSPHoC-9XntXmKqKnKntXa8QuzeReJ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+of+Specific+Hemoglobin+Adduct+Patterns+in+Users+of+Different+Tobacco%2Fnicotine+Products+by+Nontargeted+GC-MS%2FMS+Analysis&rft.jtitle=Chemical+research+in+toxicology&rft.au=Pilz%2C+Fabian&rft.au=Burkhardt%2C+Therese&rft.au=Scherer%2C+Gerhard&rft.au=Scherer%2C+Max&rft.date=2024-11-18&rft.issn=1520-5010&rft.eissn=1520-5010&rft.volume=37&rft.issue=11&rft.spage=1884&rft_id=info:doi/10.1021%2Facs.chemrestox.4c00258&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0893-228X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0893-228X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0893-228X&client=summon |